275 related articles for article (PubMed ID: 28181950)
1. Clinicopathologic and Molecular Pathology of Collecting Duct Carcinoma and Related Renal Cell Carcinomas.
Seo AN; Yoon G; Ro JY
Adv Anat Pathol; 2017 Mar; 24(2):65-77. PubMed ID: 28181950
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.
Ohe C; Smith SC; Sirohi D; Divatia M; de Peralta-Venturina M; Paner GP; Agaimy A; Amin MB; Argani P; Chen YB; Cheng L; Colecchia M; Compérat E; Werneck da Cunha I; Epstein JI; Gill AJ; Hes O; Hirsch MS; Jochum W; Kunju LP; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Nesi G; Osunkoya AO; Picken MM; Rao P; Reuter VE; de Oliveira Salles PG; Schultz L; Tickoo SK; Tomlins SA; Trpkov K; Amin MB
Am J Surg Pathol; 2018 Mar; 42(3):279-292. PubMed ID: 29309300
[TBL] [Abstract][Full Text] [Related]
3.
Wangsiricharoen S; Zhong M; Ranganathan S; Matoso A; Argani P
Int J Surg Pathol; 2021 Oct; 29(7):808-814. PubMed ID: 33729862
[TBL] [Abstract][Full Text] [Related]
4. Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method.
Sugawara E; Togashi Y; Kuroda N; Sakata S; Hatano S; Asaka R; Yuasa T; Yonese J; Kitagawa M; Mano H; Ishikawa Y; Takeuchi K
Cancer; 2012 Sep; 118(18):4427-36. PubMed ID: 22252991
[TBL] [Abstract][Full Text] [Related]
5. Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: A unique case from an older patient without clinical evidence of sickle cell trait.
Wang XT; Fang R; Ye SB; Zhang RS; Li R; Wang X; Ji RH; Lu ZF; Ma HH; Zhou XJ; Xia QY; Rao Q
Pathol Res Pract; 2019 Nov; 215(11):152651. PubMed ID: 31563285
[TBL] [Abstract][Full Text] [Related]
6. Emerging Entities in Renal Neoplasia.
Mehra R; Smith SC; Divatia M; Amin MB
Surg Pathol Clin; 2015 Dec; 8(4):623-56. PubMed ID: 26612218
[TBL] [Abstract][Full Text] [Related]
7. A case of anaplastic lymphoma kinase-positive renal cell carcinoma coincident with Hodgkin lymphoma.
Oyama Y; Nishida H; Kusaba T; Kadowaki H; Arakane M; Daa T; Watanabe D; Akita Y; Sato F; Mimata H; Yokoyama S
Pathol Int; 2017 Dec; 67(12):626-631. PubMed ID: 29024210
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review.
Yu W; Wang Y; Jiang Y; Zhang W; Li Y
Histopathology; 2017 Jul; 71(1):53-62. PubMed ID: 28199742
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
Sudarshan S; Pinto PA; Neckers L; Linehan WM
Nat Clin Pract Urol; 2007 Feb; 4(2):104-10. PubMed ID: 17287871
[TBL] [Abstract][Full Text] [Related]
10. ALK-rearranged renal cell carcinomas in children.
Cajaiba MM; Jennings LJ; Rohan SM; Perez-Atayde AR; Marino-Enriquez A; Fletcher JA; Geller JI; Leuer KM; Bridge JA; Perlman EJ
Genes Chromosomes Cancer; 2016 May; 55(5):442-51. PubMed ID: 26773439
[TBL] [Abstract][Full Text] [Related]
11. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer.
Williamson SR; Gill AJ; Argani P; Chen YB; Egevad L; Kristiansen G; Grignon DJ; Hes O
Am J Surg Pathol; 2020 Jul; 44(7):e47-e65. PubMed ID: 32251007
[TBL] [Abstract][Full Text] [Related]
12. Renal Cell Carcinoma, Unclassified with Medullary Phenotype and Synchronous Renal Clear Cell Carcinoma Present in a Patient with No Sickle Cell Trait/Disease: Diagnostic and Therapeutic Challenges.
Lai JZ; Lai HH; Cao D
Anticancer Res; 2018 Jun; 38(6):3757-3761. PubMed ID: 29848739
[TBL] [Abstract][Full Text] [Related]
13. ALK rearrangement in sickle cell trait-associated renal medullary carcinoma.
Mariño-Enríquez A; Ou WB; Weldon CB; Fletcher JA; Pérez-Atayde AR
Genes Chromosomes Cancer; 2011 Mar; 50(3):146-53. PubMed ID: 21213368
[TBL] [Abstract][Full Text] [Related]
14. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Renal Cell Carcinoma Harboring
Woo CG; Yun SJ; Son SM; Lim YH; Lee OJ
Yonsei Med J; 2020 Mar; 61(3):262-266. PubMed ID: 32102128
[TBL] [Abstract][Full Text] [Related]
16. Update on Selected High-grade Renal Cell Carcinomas of the Kidney: FH-deficient, ALK-rearranged, and Medullary Carcinomas.
Chen YB
Adv Anat Pathol; 2024 Mar; 31(2):118-125. PubMed ID: 38145398
[TBL] [Abstract][Full Text] [Related]
17. A review of ALK-rearranged renal cell carcinomas with a focus on clinical and pathobiological aspects.
Kuroda N; Sugawara E; Kusano H; Yuba Y; Yorita K; Takeuchi K
Pol J Pathol; 2018; 69(2):109-113. PubMed ID: 30351856
[TBL] [Abstract][Full Text] [Related]
18. Low-grade Oncocytic Fumarate Hydratase-deficient Renal Cell Carcinoma: An Update on Biologic Potential, Morphologic Spectrum, and Differential Diagnosis With Other Low-grade Oncocytic Tumors.
Hamza A; Sirohi D; Smith SC; Amin MB
Adv Anat Pathol; 2021 Nov; 28(6):396-407. PubMed ID: 34561376
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum.
Debelenko LV; Raimondi SC; Daw N; Shivakumar BR; Huang D; Nelson M; Bridge JA
Mod Pathol; 2011 Mar; 24(3):430-42. PubMed ID: 21076462
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
